Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-146646

BIOCEPT INC · BIOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael W. Nall
Officer — CEO & President · Director
Period of report
Oct 19, 2016
Accepted (ET)
Oct 21, 2016 · 6:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Apr 30, 2015G4,000$0.00D34,212D
Common StockF3Apr 30, 2015G4,000$0.00A4,000IBy trust
Common StockF1Sep 1, 2015G4,762$0.00D29,450D
Common StockF4Sep 1, 2015G4,762$0.00A8,762IBy trust
Common StockF1Mar 9, 2016G4,450$0.00D25,000D
Common StockF5Mar 9, 2016G4,450$0.00A13,212IBy trust
Common StockF6Oct 19, 2016P36,363$1.10A49,575IBy trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant to Purchase Common StockF6$1.10Oct 19, 2016P36,363AOct 19, 2016Oct 19, 2021Common Stock36,36336,363D

Explanation of responses